Pharma pricing and antitrust law

With US sales of close to $300 billion dollars during 2015, the pharmaceutical industry is both a vital part of the national economy and an intensely competitive business. As in any competitive business, price competition, including discounts and rebates, can […]

Read More

5 CAPA best practices for clinical research

In pharmaceutical and biopharmaceutical manufacturing, it is generally assumed that somewhere along the process of manufacturing a product, something is likely to go wrong that could affect quality. When that happens, the quality issue must be resolved in a timely, […]

Read More

They don’t call them ‘vaults’ for nothing

In case you were wondering what pharma distributors striving to meet DEA requirements for controlled-substances (Class II, or “CII”) distribution do, here’s some illustration from Woodfield Distribution LLC (WDSrx), which recently completed an expansion (to 2,600 sq. ft) for CII […]

Read More

Home infusion patient satisfaction to be studied

Following through on an initiative announced at its 2016 annual meeting (New Orleans, March 21-24), the National Home Infusion Foundation has launched a “patient satisfaction survey” study. The immediate goal is to “develop a validated, standardized set of patient satisfaction […]

Read More